Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Baseline Diabetic Nephropathy and Preoperative Glycemic Control on the Incidence of Pseudophakic Macular Edema Following Phacoemulsification A Retrospective Cohort Study With ROC-Optimized HbA1c Threshold Analysis.

NCT07723846 is registered in ClinicalTrials.gov with Thammasat University Hospital as lead sponsor.

NCT NCT07723846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07723846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Baseline Diabetic Nephropathy and Preoperative Glycemic Control on the Incidence of Pseudophakic Macular Edema Following Phacoemulsification A Retrospective Cohort Study With ROC-Optimized HbA1c Threshold Analysis.
Lead sponsor
Thammasat University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
June 1, 2026
Completion date
November 1, 2026
Enrollment
428 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract (post-operative cataract surgery follow-up), cataract and iol surgery, diabetes mellitus, type 2, diabetic nephropathies, pseudophakic macular edema